Instrumento Inactivo

Otros idiomas CorMedix Inc. Nyse

Acciones

US21900C1009

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

CORMEDIX INC. TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES	13/05
CorMedix Inc. to Participate in Two Upcoming Investor Conferences	10/05
CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
CorMedix: Q1 Earnings Snapshot	09/05
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	09/05
Actinium Pharmaceuticals (ATNM) Poised for Breakout as Analysts Project Significant Upside	09/05
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024	06/05
CORMEDIX INC. ANNOUNCES CMS GRANTS TDAPA TO DEFENCATH	22/04
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath	19/04
CORMEDIX INC. ANNOUNCES U.S. INPATIENT COMMERCIAL AVAILABILITY OF DEFENCATH	16/04
CorMedix's DefenCath Now Commercially Available For US Inpatient Use	15/04
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)	15/04
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin)	15/04
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference	11/04
Sector Update: Health Care Stocks Decline Late Afternoon	08/04
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization	08/04
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC	08/04
CorMedix Inc. Announces Commercial Agreement with ARC Dialysis, LLC	08/04
CorMedix Inc. to Present at the Needham Annual Healthcare Conference	27/03
Sector Update: Health Care Stocks Ease Wednesday Afternoon	13/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas CorMedix Inc. Nyse

Acciones

US21900C1009

Otros idiomas

Filtros